Emerging Sensing Technologies for Liquid Biopsy Applications: Steps Closer to Personalized Medicine

Emerging Sensing Technologies for Liquid Biopsy Applications: Steps Closer to Personalized Medicine

Liquid biopsy is an efficient diagnostic/prognostic tool for tumor-derived component detection in peripheral circulation and other body fluids. The rapid assessment of liquid biopsy techniques facilitates early cancer diagnosis and prognosis. Early and precise detection of tumor biomarkers provides...

Full description

Saved in:

Bibliographic Details
Main Authors:	Panagiota M. Kalligosfyri, Eleni Lamprou, Despina P. Kalogianni
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Sensors
Subjects:	microRNA circulating tumor DNA circulating tumor cells exosomes optical sensors lateral flow assay
Online Access:	https://www.mdpi.com/1424-8220/24/24/7902
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Liquid biopsy in gallbladder carcinoma: Current evidence and future prospective
by: Sridhar Mishra, et al.
Published: (2024-12-01)

Opportunities and challenges of liquid biopsy in liver cancer
by: Yu-Chen Zhong, et al.
Published: (2023-12-01)

Beyond tissue: Liquid biopsy's promise in unmasking oral cancer
by: Sakshi Deorah, et al.
Published: (2024-03-01)

Global research trends in liquid biopsy for ovarian cancer from 1999 to 2023: A 25-year bibliometric analysis
by: Jixian Wan, et al.
Published: (2024-09-01)

Establishment of liquid biopsy procedure for the analysis of circulating cell free DNA, exosomes, RNA and proteins in colorectal cancer and adenoma patients
by: Andrea Čeri, et al.
Published: (2024-11-01)

Liquid biopsy: paving a new avenue for cancer research
by: Keerthi Kurma, et al.
Published: (2024-12-01)

Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine
by: Oluwaseun Adebayo Bamodu, et al.
Published: (2023-12-01)

Liquid biopsy kinetics and detection of ERBB2 amplification/HER2-positivity in refractory hepatocellular carcinoma
by: Aaditya Srivant Geddam, et al.
Published: (2023-12-01)

Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges
by: Lingyu Li, et al.
Published: (2024-11-01)

Exosomes-based liquid biopsy: An effective approach for drugs and therapeutics resistance screening in cancer
by: Sidhanti Nyahatkar, et al.
Published: (2024-06-01)

Comprehensive characterization of circulating tumor cells and cell‐free DNA in patients with metastatic melanoma
by: Manouk K. Bos, et al.
Published: (2024-11-01)

Exploring the clinical utility of liquid biopsy with cfDNA in cancer: A systematic review
by: Keerthi Ranganathan, et al.
Published: (2024-09-01)

Novel biomarkers for monitoring and management of hepatocellular carcinoma
by: Roya Solhi, et al.
Published: (2024-12-01)

MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells
by: Anna Laura Di Pace, et al.
Published: (2023-12-01)

Development and validation of a novel combinational index of liquid biopsy biomarker for longitudinal lung cancer patient management
by: Min-Yi Liao, et al.
Published: (2024-12-01)

Identifying Hub Genes and miRNAs Associated with Alzheimer’s Disease: A Bioinformatics Pathway to Novel Therapeutic Strategies
by: Elisa Gascón, et al.
Published: (2024-12-01)

Small but mighty: Platelets as multifunctional architects of tumor metastasis and immune regulation
by: Leyi Tang, et al.
Published: (2024-12-01)

Cellular residual disease (CRD) in early breast cancer –Expanding the concept of minimal residual disease monitoring?
by: Mara S. Serafini, et al.
Published: (2024-03-01)

Mapping the Future: A Comprehensive Bibliometric Analysis of Circulating Tumor DNA in Colorectal Cancer
by: Wang C
Published: (2024-11-01)

Levels of circulating tumor DNA correlate with tumor volume in gastro‐intestinal stromal tumors: an exploratory long‐term follow‐up study
by: Roos F. Bleckman, et al.
Published: (2024-11-01)

Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer
by: Jinghan Song, et al.
Published: (2024-12-01)

Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
by: Martina Ruglioni, et al.
Published: (2025-02-01)

Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors
by: Ekaterina Kalashnikova, et al.
Published: (2024-11-01)

Pretreatment level of circulating tumor cells is associated with lymph node metastasis in papillary thyroid carcinoma patients with ≤ 55 years old
by: Ming Yu, et al.
Published: (2025-01-01)

Differential expression of circulating microRNAs in lactating Holstein and Jersey cows exposed to heat stress
by: Jihwan Lee, et al.
Published: (2024-12-01)

Potential of circulating tumour DNA as a biomarker in liquid biopsy
by: Dimitar Dimitrov, et al.
Published: (2023-03-01)

Exosomes and microRNAs as mediators of the exercise
by: Haoyuan Li, et al.
Published: (2025-01-01)

Lateral Flow Assay for Preeclampsia Screening Using DNA Hairpins and Surface-Enhanced Raman-Active Nanoprobes Targeting hsa-miR-17-5p
by: Ka Wai Ng, et al.
Published: (2024-11-01)

Concordance of HER2 status between primary tumor and circulating tumor cells in breast cancer
by: Peipei Xie, et al.
Published: (2024-12-01)

Cancer-associated macrophage-like cells as a prognostic biomarker in solid tumors
by: Anthony Pirrello, et al.
Published: (2024-12-01)

Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases
by: Aakash Desai, et al.
Published: (2024-06-01)

Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomas
by: D. Yu. Gvaldin, et al.
Published: (2024-06-01)

A revolutionary era in advancing precision immuno-oncology; role of circulating tumor cells
by: Nazila Bahmaie, et al.
Published: (2024-12-01)

CORRELATION OF THE OBJECTS OF CIVIL RIGHTS WITHDRAWN, RESTRICTED OR PROHIBITED FOR CIRCULATION
by: E. V. Luneva
Published: (2014-03-01)

Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREEN
by: Saori Mishima, et al.
Published: (2023-09-01)

The clinical utility of circulating human papillomavirus across squamous cell carcinomas
by: Karen-Lise G. Spindler, et al.
Published: (2025-01-01)

Advanced surgical techniques and considerations in carotid body tumor management: insights from a cohort study
by: Farooq Ahmad Ganie, et al.
Published: (2025-02-01)

Immunolipid magnetic bead-based circulating tumor cell sorting: a novel approach for pathological staging of colorectal cancer
by: Qingyan Deng, et al.
Published: (2025-01-01)

Discovery of miRNA–mRNA regulatory networks in glioblastoma reveals novel insights into tumor microenvironment remodeling
by: Iulia A. Grigore, et al.
Published: (2024-11-01)

Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy
by: Yeochan Yun, et al.
Published: (2024-12-01)